New education programmes in fermentation and bioprocessing strengthen the Dutch pharma ecosystem

News May 7, 2026

fermentation and bioprocessing

“Those who don’t understand the latest technologies risk losing the competitive position of the Dutch pharmaceutical value chain,” warns Sven Stielstra, manager LIFE Capital at the LIFE Cooperative and project lead of the new PharmaNL initiative Fermentation and Bioprocessing for Smart and Sustainable Pharma. This project, launched at the beginning of 2026 within PharmaNL’s Human Capital Growth program, aims to strengthen the skills and knowledge of professionals in the pharmaceutical sector. Together with a consortium of companies and knowledge institutions, the project ensures that employees in fermentation and bioprocessing stay ahead in a constantly evolving field.

The initiative addresses the practical challenges of the sector. “The field is incredibly dynamic,” explains Stielstra. “New technologies, automation, and stricter regulations continuously change processes. Professionals who are not prepared for these shifts risk losing both their own edge and their company’s competitive position.”

By training professionals more efficiently, the project helps scale up the production of new therapies, including cell therapies and other bioproducts. This reduces the time before innovative treatments reach patients and strengthens the international competitiveness of Dutch companies, contributing to a future-proof and sustainable pharmaceutical sector.

Three Progressive Modules

The training program consists of three modules, tailored to experience and practical application. The first module covers emerging technologies that will shape the sector in the near future. These lectures are primarily aimed at leading scientists and business developers who need to anticipate upcoming changes.

The second module combines theory and practice: professionals learn to design processes more efficiently, with a focus on automation, data analysis, and compliance. “Everything needs to be better, faster, and meet stricter requirements. Those who understand the rules and processes can work much more efficiently,” emphasizes Stielstra.

The third module is fully hands-on, allowing participants to practice directly in a production environment. They learn to follow protocols, apply technology, and adhere to safety procedures to contribute effectively to efficient and sustainable production. Stielstra adds: “The program is flexible: participants can choose classroom training, hands-on practice, or a combination of both. This allows us to provide tailored, relevant education for their company.”

From mbo to University Level

The project targets professionals with diverse backgrounds. Biologists and technicians learn to understand each other’s disciplines and collaborate effectively. “In practice, these worlds need to work together, yet they often never meet during their education. Our modular approach shortens the learning curve and prevents miscommunication,” says Stielstra.

By offering modular education, companies can train their employees faster. “Companies currently report that it takes a year to fully operationalize new talent. Our modules aim to shorten that process significantly,” Stielstra adds.

Collaboration and Pilots

The project is carried out in collaboration with knowledge partners and companies such as Noorderpoort, NHL Stenden, Hanze University, Thermo Fisher Scientific Groningen, EV Biotech, and Regenity. “This project truly started from the needs of the industry. Companies asked us to do this, contributed ideas, and co-funded the initiative. That’s what makes it unique and effective,” says Stielstra.

Pilots will be run to refine the modules. In the first year, the focus is on identifying workplace-specific challenges; the second year focuses on developing the training; and the third year on evaluation and finalization. PharmaNL’s objective is that the first module should be ready six months before the project ends.

Unique Profile and Long-Term Impact

The project creates a unique professional profile: individuals who understand both biology and engineering and can collaborate effectively in production environments. “Until now, these were separate worlds. Now we are creating a profile that masters both, which is exactly what the industry needs,” says Stielstra.

The training targets professionals already active in the sector and is designed to run independently after three years. This enables companies across the Netherlands to upskill their employees efficiently, helping the field respond faster to new technologies and accelerate the production of innovative medicines. The combination of theory, practice, and multidisciplinary collaboration ensures that the education is immediately applicable and future-proof.

“Our success formula is simple: a project by and for industry, together with knowledge partners, creating education that is both practical and alive. This is how we ensure professionals stay ahead in a rapidly changing field,” concludes Stielstra.

Learn More

For more information, contact Sven Stielstra via sven@lifecooperative.nl or visit the website of the LIFE Cooperative.